Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Gastroenterology · Minimal Change Esophagitis

What Does LA-M Esophagitis Mean and How Is It Treated?

At a Glance

LA-M, or minimal change esophagitis, describes subtle redness or texture changes without visible breaks in the esophageal lining. It does not prove or rule out GERD, so treatment depends on symptoms, biopsies, alarm signs, and sometimes reflux monitoring.

Seeing medical terms like “erythema” (redness) or “LA-M” on your endoscopy report can be alarming. However, LA-M simply stands for minimal change esophagitis, which means the doctor noticed subtle visual changes—such as mild redness, slight swelling, or pale tissue—but no visible mucosal breaks or erosions in the esophageal lining [1][2][3]. Finding out you have LA-M does not automatically prove you have acid reflux disease (GERD), nor does it completely rule it out, and it does not necessarily mean you need aggressive treatment.

What LA-M Means in Your Report

Endoscopists use the Los Angeles (LA) Classification System to grade the extent of visible erosive injury in suspected reflux esophagitis on a scale from A to D. To qualify for Grade A (the mildest official grade), there must be at least one visible mucosal break. Because LA-M involves only mild color or texture changes without any visible tissue breaks, it is not part of the original, standardized LA grading system [4]. Some doctors use “LA-M” locally to note these subtle findings, while others might simply note a normal-appearing esophagus.

Medical guidelines, including the international standard known as the Lyon Consensus 2.0, do not consider minimal change findings to be definitive proof of GERD [5][6] because:

  • It is highly subjective: Doctors frequently disagree on whether minimal changes are actually present. What looks like mild redness to one doctor might look completely normal to another [7][4].
  • It is not specific to acid reflux: While minimal changes can be associated with GERD, they are also frequently found in the esophaguses of completely healthy people who do not have acid reflux [8][2].

At the same time, having a normal or minimally changed esophagus does not rule out GERD. Many people with bothersome symptoms have non-erosive reflux disease (NERD), where reflux occurs without causing visible mucosal breaks or erosions to the lining [9][10].

When to Seek Urgent Care (Alarm Symptoms)

While typical reflux symptoms include heartburn and regurgitation, certain symptoms require prompt or urgent medical evaluation rather than an unsupervised medication trial.

  • Seek emergency care if you experience new, severe, exertional, or unexplained chest pain, especially if accompanied by shortness of breath, sweating, faintness, or pain spreading to the arm, jaw, or back [10][11].
  • Contact your clinician promptly if you experience alarm symptoms such as difficulty swallowing (dysphagia), food sticking in your throat or chest, vomiting blood, black or tarry stools, unintentional weight loss, persistent vomiting, or anemia [9][11].

How Treatment is Determined

Because LA-M on its own does not reliably prove you have GERD, doctors typically do not base your treatment on this visual finding alone [9]. Instead, management depends on your symptoms, the full endoscopy report (including any biopsy results), and the presence of any alarm features.

  • If you have bothersome, typical symptoms (without alarm features): Your doctor may recommend a clinician-guided trial of a Proton Pump Inhibitor (PPI), usually taken once daily before a meal for 4 to 8 weeks, to see if reducing stomach acid relieves your symptoms [9][12]. However, symptom improvement alone does not definitively confirm GERD [10].
  • If you have no symptoms or very mild symptoms: Finding LA-M during an endoscopy done for another reason often requires no acid-reducing medication at all, provided there are no other concerning findings (like microscopic inflammation seen on biopsies) [9].
  • If symptoms don’t improve with medication: Lack of response to a PPI does not automatically mean you need a specific test; your doctor will first review how you take the medication and consider alternative diagnoses. If GERD is still suspected but unproven, your doctor may recommend ambulatory reflux monitoring off medication [13][9]. This testing measures your esophageal acid exposure over a 24- to 96-hour period (depending on the device used) and evaluates whether your symptoms associate with reflux events [14].

Finding LA-M on an endoscopy report is a nonspecific observation and is usually not an emergency. Do not start or stop long-term medications based solely on this term. Always discuss the full results—including any biopsies or other structural findings—with your care team to determine the best path forward.

Common questions in this guide

What does LA-M mean on an endoscopy report?
LA-M means the endoscopist saw subtle changes such as mild redness, slight swelling, or a change in color or texture without a visible break or erosion in the esophageal lining. It is a local term for a minimal finding, not one of the original standardized Los Angeles grades.
Does LA-M prove that I have GERD?
No. Minimal changes can be seen in people without reflux, and a normal-looking or minimally changed esophagus can also occur with non-erosive reflux disease. Doctors interpret the finding along with your symptoms, biopsies, and other test results.
Do I need medicine if LA-M was found?
Not necessarily. If you have no symptoms or only very mild symptoms and no other concerning findings, your clinician may recommend no acid-reducing medicine; if typical symptoms are bothersome, they may suggest a once-daily PPI before a meal for 4 to 8 weeks. Do not start or stop long-term medication based on LA-M alone.
What if my reflux symptoms do not improve with a PPI?
Your clinician may first check whether the medicine is being taken at the right time and consider other causes of your symptoms. If GERD remains suspected but has not been proven, ambulatory reflux monitoring off medication may measure acid exposure and whether symptoms occur with reflux over 24 to 96 hours.
Which symptoms with LA-M need urgent medical attention?
New, severe, activity-related, or unexplained chest pain—especially with shortness of breath, sweating, faintness, or pain spreading to the arm, jaw, or back—requires emergency care. Difficulty swallowing, food sticking, vomiting blood, black or tarry stools, unintentional weight loss, persistent vomiting, or anemia should be reported promptly to a clinician.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Were biopsies taken during my endoscopy, and did they show any microscopic inflammation or other findings that would change my treatment?
  2. 2.Do my symptoms, rather than just the LA-M finding, suggest that I need to start a trial of acid-reducing medication?
  3. 3.If I start a trial of a PPI, how exactly should I take it (e.g., timing before meals), and how long should we wait before evaluating if it is working?
  4. 4.If my symptoms don't improve, what are our next steps for investigating the cause?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Multichannel impedance monitoring for distinguishing nonerosive reflux esophagitis with minor changes on endoscopy in children.

    Junko F, Moore D, Omari T, et al.

    Therapeutic advances in gastrointestinal endoscopy 2021; (14()):26317745211030466 doi:10.1177/26317745211030466.

    PMID: 34350397
  2. 2

    Evaluation of Minimal Change Lesions Using Linked Color Imaging in Patients With Nonerosive Reflux Esophagitis.

    Zhang NN, Ma YM, Sun Q, et al.

    Journal of clinical gastroenterology 2022; (56(5)):405-411 doi:10.1097/MCG.0000000000001538.

    PMID: 33852447
  3. 3

    Comparison of Los Angeles Grades of Erosive Esophagitis Scored by Local Investigators vs Central Adjudicators in a Clinical Trial.

    Spechler SJ, Laine L, DeVault KR, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024; (22(12)):2526-2528.e1 doi:10.1016/j.cgh.2024.05.007.

    PMID: 38777170
  4. 4

    [Minimal Change Esophagitis].

    Ryu HS, Choi SC

    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2016; (67(1)):4-7 doi:10.4166/kjg.2016.67.1.4.

    PMID: 26809625
  5. 5

    The Los Angeles-B esophagitis is a conclusive diagnostic evidence for gastroesophageal reflux disease: the validation of Lyon Consensus 2.0.

    Chen J, Dong P, Chen S, et al.

    Gastroenterology report 2025; (13()):goaf004 doi:10.1093/gastro/goaf004.

    PMID: 40083682
  6. 6

    [Modern Diagnostic Strategies for Gastroesophageal Reflux Disease: Focus on Lyon Consensus 2.0].

    Lee TH

    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2026; (86(3)):193-198 doi:10.4166/kjg.2026.038.

    PMID: 42494146
  7. 7

    Inter-observer variability of experts and trainees for the diagnosis of reflux esophagitis: Comparison of linked color imaging, blue laser imaging, and white light imaging.

    Lee SP, Kae SH, Jang HJ, et al.

    Journal of digestive diseases 2021; (22(7)):425-432 doi:10.1111/1751-2980.13023.

    PMID: 34036751
  8. 8

    i-Scan detection of minimal change esophagitis in dyspeptic patients with or without Gastroesophageal Reflux disease.

    Netinatsunton N, Sottisuporn J, Attasaranya S, et al.

    BMC gastroenterology 2016; (16()):4 doi:10.1186/s12876-016-0417-4.

    PMID: 26762316
  9. 9

    AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.

    Yadlapati R, Gyawali CP, Pandolfino JE,

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(5)):984-994.e1 doi:10.1016/j.cgh.2022.01.025.

    PMID: 35123084
  10. 10

    Phenotyping and symptom diagnostic accuracy in unproven gastroesophageal reflux disease (GERD): An experience from Saudi GI Motility Labs.

    Alzahrani MA, Almanjahi IM, Alquzi AA, et al.

    Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association 2026; doi:10.4103/sjg.sjg_43_26.

    PMID: 41793389
  11. 11

    [Personalized diagnosis of patients with gastroesophageal reflux disease using 24-hour pH-impedance testing and high-resolution esophageal manometry].

    Maev IV, Yurenev GL, Barkalova EV, et al.

    Terapevticheskii arkhiv 2024; (96(8)):757-763 doi:10.26442/00403660.2024.08.202816.

    PMID: 39404720
  12. 12

    Medical Treatment of Gastroesophageal Reflux Disease.

    Kroch DA, Madanick RD

    World journal of surgery 2017; (41(7)):1678-1684 doi:10.1007/s00268-017-3954-2.

    PMID: 28321555
  13. 13

    Reflux Testing: Wireless pH, Impedance-pH, and Mucosal Impedance.

    Krause A, Yadlapati R

    Gastrointestinal endoscopy clinics of North America 2025; (35(3)):587-601 doi:10.1016/j.giec.2024.12.007.

    PMID: 40412992
  14. 14

    Updates to the modern diagnosis of GERD: Lyon consensus 2.0.

    Gyawali CP, Yadlapati R, Fass R, et al.

    Gut 2024; (73(2)):361-371 doi:10.1136/gutjnl-2023-330616.

    PMID: 37734911

This page is for informational purposes only and does not constitute medical advice. It explains LA-M findings, but your clinician should interpret your full endoscopy report and guide any treatment.

Get notified when new evidence is published on peptic esophagitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.